Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection

Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection

US Patent 12303525 · Granted May 20, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligonucleotides for modulating RTEL1 expression2025
Oligonucleotides for modulating RTEL1 expression2025
Oligonucleotides for inducing paternal UBE3A expression2025
Oligonucleotides for modulating SCN9A expression2024
Enhanced oligonucleotides for inhibiting RTEL1 expression2024
Enhanced oligonucleotides for inhibiting RTEL1 expression2024
Oligonucleotides for inducing paternal UBE3A expression2023
Use of FUBP1 inhibitors for treating hepatitis B virus infection2023
Use of FUBP1 inhibitors for treating hepatitis B virus infection2023
Antisense oligonucleotides targeting ATXN32023
Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatit2022
Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatit2022